Biopharmaceutical company BlueRock Therapeutics, a subsidiary of Bayer AG, partners with Rune Labs for clinical trial platform to monitor Parkinson’s disease. The study uses the FDA-approved Apple Watch for data collection, a tool for recording tremors and uncontrolled body movements (dyskinesia), and an app allows patients to record medications, side effects and symptoms. The study will investigate the effects of disease-modifying therapeutics for the treatment of movement disorders.
LINK